The Christie Foundation Trust Annual Report and Accounts 2021-22

Remuneration report

* S Parkinson and N Bayman salary details are pro-rata for the time in the roles during the financial year, the pensions element is reflective of the full year benefit from their previous roles. ** The remuneration for Dr Makin disclosed above is the total remuneration package. A small proportion of Dr Makin's package relates to her clinical role ***The remuneration for Professor Chris Harrison disclosed above is the total remuneration package for his role as Executive Medical Director (Strategy) at The Christie NHS Foundation Trust. ****Mr Ainsworth received £3,000 for his role as Chair of The Christie Pharmacy Limited, a wholly owned subsidiary of The Christie NHS Foundation Trust. Remuneration for the year ending 31st March 2022 was £3,000. The Executive Directors of The Christie Pharmacy Limited are Senior Managers employed by The Christie NHS Foundation Trust and are not included in the table above. Both Executive Directors of the subsidiary company received additional remuneration for these roles of £3,000 per annum. The value of pension benefits accrued during the year is calculated as the real increase in pension multiplied by 20, less the contributions made by the individual. The real increase excludes increases due to inflation or any increase or decrease due to a transfer of pension rights. This value derived does not represent an amount that will be received by the individual. It is a calculation that is intended to provide an estimation of the benefit being a member of the pension scheme could provide. The pension benefit table provides further information on the pensions benefits accruing to the individual. NHS foundation trusts are required to disclose the relationship between the remuneration of the highest-paid director in their organisation and the lower quartile, median and upper quartile remuneration of the organisation's workforce. This is detailed in the Remuneration Pay table above. The banded remuneration of the highest paid director in The Christie in the financial year 2021-22 was £240,000 - £245,000 (2019-20 £235,000 - £240,000). This was 7.5 times (2020-21 7.6 times) the median remuneration of the workforce, which was £32,306 (2020-21 £31,365). In both 2020-21 and 2021-22 no employee received remuneration in excess of the highest paid director. For employees of the Trust as a whole, the range of remuneration in 2021-22 was from £9,034 to £243,300 (2020-21 was £18,005 to £239,479). The percentage change in average employee remuneration (based on total for all employees on an annualised basis divided by full time equivalent number of employees) between years is 3.59%. No employees received remuneration in excess of the highest-paid director in 2021-22. Total remuneration includes salary, non-consolidated performance-related pay, benefits-in-kind but not severance payments. It does not include employer pension contributions and the cash equivalent transfer value of pensions.

130